An association between gene expression and better survival in female mice following myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 801-811

  Chen, Quanhai ^a   Williams, Roy ^b   Healy, Chastity L ^a   Wright, Casey D ^a   Wu, Steven C ^a   O'Connell, Timothy D ^a  

^a SANFORD RESEARCH   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Heart failure; Microarray; Myocardial infarction; Sex gender

Indexed keywords

A SYNTHASE 2; ANGIOPOIETIN LIKE 4; ANKYRIN REPEAT DOMAIN 1; C TYPE LECTIN DOMAIN FAMILY 4 MEMBER N; CARBOXYLESTERASE 3; COLLAGEN TYPE 8 ALPHA 1; CXCL4 CHEMOKINE; CYSTATIN B; CYTOKINE RECEPTOR LIKE FACTOR 1; DIMETHYLARGININASE 1; FC RECEPTOR LIKE PROTEIN 3; FK506 BINDING PROTEIN 11; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; GLYCOPROTEIN NMB; INTEGRIN BETA 1 BINDING PROTEIN 3; LECTIN GALACTOSIDE BINDING SOLUBLE 3; LYSYL OXIDASE LIKE 1; LYSYL OXIDASE LIKE 2; MATRIX METALLOPEPTIDASE 12; MATRIX METALLOPROTEINASE 14; PEPTIDYLPROLYL ISOMERASE C; POLO LIKE KINASE 1; RETINOL BINDING PROTEIN 1; SEX HORMONE; SPHINGOSINE KINASE 1; SUSHI REPEAT CONTAINING PROTEIN X LINKED 2; SYNAPTOPODIN; TYRO PROTEIN TYROSINE KINASE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CELL REGENERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; HEART DILATATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MOVEMENT; HEART MUSCLE FIBROSIS; HEART SURGERY; IMMUNE RESPONSE; MALE; MICROARRAY ANALYSIS; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SHAM PROCEDURE; SURVIVAL RATE;

ANIMALS; CAPILLARIES; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HEART FUNCTION TESTS; HEART VENTRICLES; MALE; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; SEX CHARACTERISTICS; SURVIVAL ANALYSIS; VENTRICULAR REMODELING;

MUS;

EID: 77957245096     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.002     Document Type: Article

References (31)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation Jan 29 2008, 117(4):e25-e146.
2. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA Jul 3 2002, 288(1):49-57.
3. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA Jul 17 2002, 288(3):321-333.
4. Cavasin M.A., Sankey S.S., Yu A.L., Menon S., Yang X.P. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol May 2003, 284(5):H1560-H1569.
5. Cavasin M.A., Tao Z., Menon S., Yang X.P. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci Sep 17 2004, 75(18):2181-2192.
6. Cavasin M.A., Tao Z.Y., Yu A.L., Yang X.P. Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. Am J Physiol Heart Circ Physiol May 2006, 290(5):H2043-H2050.
7. Fang L., Gao X.M., Moore X.L., Kiriazis H., Su Y., Ming Z., et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol Nov 2007, 43(5):535-544.
8. Pelzer T., Loza P.A., Hu K., Bayer B., Dienesch C., Calvillo L., et al. Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation Mar 29 2005, 111(12):1492-1498.
9. Pedram A., Razandi M., Lubahn D., Liu J., Vannan M., Levin E.R. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. Endocrinology Jul 2008, 149(7):3361-3369.
10. Patten R.D., Pourati I., Aronovitz M.J., Baur J., Celestin F., Chen X., et al. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res Oct 1 2004, 95(7):692-699.
11. Korte T., Fuchs M., Arkudas A., Geertz S., Meyer R., Gardiwal A., et al. Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation May 10 2005, 111(18):2282-2290.
12. van Eickels M., Patten R.D., Aronovitz M.J., Alsheikh-Ali A., Gostyla K., Celestin F., et al. 17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol Jun 4 2003, 41(11):2084-2092.
13. Zhang Y., Takagawa J., Sievers R.E., Khan M.F., Viswanathan M.N., Springer M.L., et al. Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction. Am J Physiol Heart Circ Physiol Feb 2007, 292(2):H1187-H1192.
14. Moller J.E., Whalley G.A., Dini F.L., Doughty R.N., Gamble G.D., Klein A.L., et al. Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: Meta-Analysis Research Group in Echocardiography acute myocardial infarction. Circulation May 20 2008, 117(20):2591-2598.
15. Harpster M.H., Bandyopadhyay S., Thomas D.P., Ivanov P.S., Keele J.A., Pineguina N., et al. Earliest changes in the left ventricular transcriptome postmyocardial infarction. Mamm Genome Jul 2006, 17(7):701-715.
16. Kittleson M.M., Minhas K.M., Irizarry R.A., Ye S.Q., Edness G., Breton E., et al. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics May 11 2005, 21(3):299-307.
17. Boheler K.R., Volkova M., Morrell C., Garg R., Zhu Y., Margulies K., et al. Sex- and age-dependent human transcriptome variability: implications for chronic heart failure. Proc Natl Acad Sci USA Mar 4 2003, 100(5):2754-2759.
18. Witt H., Schubert C., Jaekel J., Fliegner D., Penkalla A., Tiemann K., et al. Sex-specific pathways in early cardiac response to pressure overload in mice. J Mol Med Sep 2008, 86(9):1013-1024.
19. Weinberg E.O., Mirotsou M., Gannon J., Dzau V.J., Lee R.T., Pratt R.E. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics Jan 15 2003, 12(2):113-127.
20. Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest Aug 2005, 115(8):2108-2118.
21. Heineke J., Auger-Messier M., Xu J., Oka T., Sargent M.A., York A., et al. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest Nov 2007, 117(11):3198-3210.
22. van der Laan A.M., Piek J.J., van Royen N. Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat Rev Cardiol Aug 2009, 6(8):515-523.
23. Jacobi J., Sydow K., von Degenfeld G., Zhang Y., Dayoub H., Wang B., et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation Mar 22 2005, 111(11):1431-1438.
24. Limaye V. The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology. Endothelium May-Jun 2008, 15(3):101-112.
25. Duan H.F., Wang H., Yi J., Liu H.J., Zhang Q.W., Li L.B., et al. Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia/reperfusion-induced injury and attenuates its postischemic failure. Hum Gene Ther Nov 2007, 18(11):1119-1128.
26. Lindsey M., Wedin K., Brown M.D., Keller C., Evans A.J., Smolen J., et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation May 1 2001, 103(17):2181-2187.
27. Lambert J.M., Lopez E.F., Lindsey M.L. Macrophage roles following myocardial infarction. Int J Cardiol Nov 12 2008, 130(2):147-158.
28. Konhilas J.P., Leinwand L.A. The effects of biological sex and diet on the development of heart failure. Circulation Dec 4 2007, 116(23):2747-2759.
29. Mohandas B., Mehta J.L. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. Curr Opin Cardiol Sep 2007, 22(5):434-442.
30. Herrington D.M., Klein K.P. Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings. Atherosclerosis Feb 2003, 166(2):203-212.
31. Rossouw J.E., Prentice R.L., Manson J.E., Wu L., Barad D., Barnabei V.M., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA Apr 4 2007, 297(13):1465-1477.